日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/01/22 | 8,040 | 8,080 | 8,020 | 8,050 | -30 | -0.4% | 167,200 |
| 2018/01/19 | 8,020 | 8,150 | 8,020 | 8,080 | +70 | +0.9% | 171,000 |
| 2018/01/18 | 8,110 | 8,150 | 8,010 | 8,010 | -10 | -0.1% | 208,700 |
| 2018/01/17 | 8,050 | 8,190 | 8,000 | 8,020 | -160 | -2% | 276,100 |
| 2018/01/16 | 8,340 | 8,340 | 8,180 | 8,180 | -70 | -0.8% | 279,000 |
| 2018/01/15 | 8,260 | 8,300 | 8,230 | 8,250 | +90 | +1.1% | 112,100 |
| 2018/01/12 | 8,030 | 8,240 | 8,000 | 8,160 | +160 | +2% | 269,300 |
| 2018/01/11 | 8,340 | 8,390 | 7,880 | 8,000 | -490 | -5.8% | 619,800 |
| 2018/01/10 | 8,760 | 8,760 | 8,490 | 8,490 | -270 | -3.1% | 364,500 |
| 2018/01/09 | 8,630 | 8,820 | 8,620 | 8,760 | ±0 | ±0% | 167,500 |
| 2018/01/05 | 8,680 | 8,780 | 8,660 | 8,760 | +90 | +1% | 124,700 |
| 2018/01/04 | 8,500 | 8,680 | 8,450 | 8,670 | +260 | +3.1% | 142,200 |
| 2017/12/29 | 8,440 | 8,470 | 8,390 | 8,410 | ±0 | ±0% | 70,100 |
| 2017/12/28 | 8,400 | 8,500 | 8,370 | 8,410 | +10 | +0.1% | 105,900 |
| 2017/12/27 | 8,430 | 8,450 | 8,370 | 8,400 | -30 | -0.4% | 85,900 |
| 2017/12/26 | 8,430 | 8,520 | 8,410 | 8,430 | +20 | +0.2% | 86,100 |
| 2017/12/25 | 8,310 | 8,480 | 8,310 | 8,410 | +140 | +1.7% | 127,000 |
| 2017/12/22 | 8,130 | 8,330 | 8,110 | 8,270 | +160 | +2% | 158,700 |
| 2017/12/21 | 8,060 | 8,130 | 8,040 | 8,110 | ±0 | ±0% | 147,800 |
| 2017/12/20 | 8,210 | 8,320 | 8,070 | 8,110 | -120 | -1.5% | 190,100 |
| 2017/12/19 | 8,380 | 8,380 | 8,220 | 8,230 | -150 | -1.8% | 97,100 |
| 2017/12/18 | 8,280 | 8,430 | 8,230 | 8,380 | +180 | +2.2% | 162,300 |
| 2017/12/15 | 8,180 | 8,240 | 8,150 | 8,200 | -20 | -0.2% | 134,800 |
| 2017/12/14 | 8,290 | 8,330 | 8,180 | 8,220 | -100 | -1.2% | 159,800 |
| 2017/12/13 | 8,140 | 8,370 | 8,140 | 8,320 | +250 | +3.1% | 301,500 |
| 2017/12/12 | 8,000 | 8,100 | 7,970 | 8,070 | +140 | +1.8% | 171,000 |
| 2017/12/11 | 7,880 | 7,950 | 7,770 | 7,930 | +110 | +1.4% | 138,700 |
| 2017/12/08 | 7,660 | 7,850 | 7,660 | 7,820 | +10 | +0.1% | 176,900 |
| 2017/12/07 | 7,690 | 7,870 | 7,680 | 7,810 | +180 | +2.4% | 149,500 |
| 2017/12/06 | 7,780 | 7,810 | 7,610 | 7,630 | -190 | -2.4% | 168,000 |
| 2017/12/05 | 7,850 | 7,850 | 7,790 | 7,820 | -100 | -1.3% | 211,800 |
| 2017/12/04 | 7,980 | 8,060 | 7,920 | 7,920 | -10 | -0.1% | 125,000 |
| 2017/12/01 | 8,010 | 8,030 | 7,900 | 7,930 | -110 | -1.4% | 135,400 |
| 2017/11/30 | 7,970 | 8,080 | 7,820 | 8,040 | +60 | +0.8% | 216,600 |
| 2017/11/29 | 8,020 | 8,060 | 7,940 | 7,980 | -80 | -1% | 165,800 |
| 2017/11/28 | 8,100 | 8,130 | 8,040 | 8,060 | +30 | +0.4% | 141,100 |
| 2017/11/27 | 8,040 | 8,060 | 7,970 | 8,030 | +100 | +1.3% | 149,200 |
| 2017/11/24 | 7,950 | 7,970 | 7,890 | 7,930 | -20 | -0.3% | 90,500 |
| 2017/11/22 | 7,980 | 8,020 | 7,950 | 7,950 | -60 | -0.7% | 152,200 |
| 2017/11/21 | 7,980 | 8,090 | 7,910 | 8,010 | -10 | -0.1% | 149,400 |
| 2017/11/20 | 7,840 | 8,050 | 7,830 | 8,020 | +150 | +1.9% | 233,600 |
| 2017/11/17 | 7,780 | 7,880 | 7,680 | 7,870 | +240 | +3.1% | 330,000 |
| 2017/11/16 | 7,370 | 7,650 | 7,360 | 7,630 | +220 | +3% | 196,900 |
| 2017/11/15 | 7,520 | 7,580 | 7,390 | 7,410 | -190 | -2.5% | 291,400 |
| 2017/11/14 | 7,760 | 7,830 | 7,580 | 7,600 | -180 | -2.3% | 345,100 |
| 2017/11/13 | 7,870 | 7,920 | 7,720 | 7,780 | -180 | -2.3% | 262,000 |
| 2017/11/10 | 7,700 | 7,990 | 7,700 | 7,960 | +150 | +1.9% | 385,300 |
| 2017/11/09 | 7,820 | 7,980 | 7,740 | 7,810 | +230 | +3% | 650,800 |
| 2017/11/08 | 7,760 | 7,770 | 7,540 | 7,580 | -160 | -2.1% | 322,700 |
| 2017/11/07 | 7,650 | 7,800 | 7,630 | 7,740 | -210 | -2.6% | 387,600 |
1801～
1850
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 353,400円 | +8.0% | -15.3% | 3.51% | 9.92倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 住友ファーマ | 80,400円 | -11.0% | +206.6% | 0.00% | 7.99倍 | 1.88倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ツムラ | 333,200円 | +3.8% | -19.9% | 4.08% | 10.90倍 | 0.83倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サンバイオ | 338,000円 | - | - | 0.00% | - | 156.55倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ペプチド | 168,300円 | +5.0% | +1.5% | 0.00% | 14.40倍 | 3.83倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム
